313 related articles for article (PubMed ID: 25333524)
1. Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.
Datta S; Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Roy G; Das S; Das K; Gupta S; Basu K; Basu A; Datta S; Chowdhury A; Banerjee S
PLoS One; 2014; 9(10):e110012. PubMed ID: 25333524
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
[TBL] [Abstract][Full Text] [Related]
3. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
5. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively.
Chen YM; Wu SH; Qiu CN; Yu DJ; Wang XJ
Braz J Med Biol Res; 2013 Jul; 46(7):614-22. PubMed ID: 23903686
[TBL] [Abstract][Full Text] [Related]
7. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
[TBL] [Abstract][Full Text] [Related]
10. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
[TBL] [Abstract][Full Text] [Related]
11. Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.
Khan A; Al Balwi MA; Tanaka Y; Hajeer A; Sanai FM; Al Abdulkarim I; Al Ayyar L; Badri M; Saudi D; Tamimi W; Mizokami M; Al Knawy B
Int J Cancer; 2013 Dec; 133(12):2864-71. PubMed ID: 23740667
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.
Lyu H; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ
J Viral Hepat; 2013 Mar; 20(3):219-24. PubMed ID: 23383661
[TBL] [Abstract][Full Text] [Related]
13. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
[TBL] [Abstract][Full Text] [Related]
15. The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease.
Al-Qahtani AA; Al-Anazi MR; Nazir N; Abdo AA; Sanai FM; Al-Hamoudi WK; Alswat KA; Al-Ashgar HI; Khan MQ; Albenmousa A; El-Shamy A; Alanazi SK; Dela Cruz D; Bohol MFF; Al-Ahdal MN
Front Cell Infect Microbiol; 2018; 8():355. PubMed ID: 30406036
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B genotype and viral basic core promoter and precore mutations among teenagers in Macao: relationship with hepatocellular carcinoma development.
Chui SH; Chen JH; Szeto YT; Yam WC
Br J Biomed Sci; 2011; 68(3):143-6. PubMed ID: 21950207
[TBL] [Abstract][Full Text] [Related]
17. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
Xu L; Chen EQ; Lei J; Liu L; Zhou TY; Gao Z; Tang H
Hepatogastroenterology; 2012; 59(113):212-5. PubMed ID: 22251541
[TBL] [Abstract][Full Text] [Related]
18. Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression.
Zhang D; Ma S; Zhang X; Zhao H; Ding H; Zeng C
BMC Infect Dis; 2010 Sep; 10():271. PubMed ID: 20846420
[TBL] [Abstract][Full Text] [Related]
19. An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People.
Hayashi S; Khan A; Simons BC; Homan C; Matsui T; Ogawa K; Kawashima K; Murakami S; Takahashi S; Isogawa M; Ikeo K; Mizokami M; McMahon BJ; Tanaka Y
Hepatology; 2019 Jan; 69(1):19-33. PubMed ID: 29893492
[TBL] [Abstract][Full Text] [Related]
20. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]